Philips and Farah Hospital expand therapy options for women with painful uterine fibroids in the Middle East

June 10, 2013

Amman, Jordan –  Royal Philips (NYSE:PHG, AEX:PHIA) and Farah Hospital  are expanding the therapy options for women with benign tumors of the uterus, also known as uterine fibroids. Farah Hospital will be the first healthcare facility in the Middle East to have a Philips Sonalleve MR-HIFU system and the ability to offer its patients an outpatient procedure with faster recovery and lower complication rates than surgical removal.
 
Uterine fibroids are one of the most common gynecological disorders, with nearly 80% of women around the globe affected by age 50. Most fibroids are asymptomatic, but about one quarter of those affected have symptoms that are severe enough to require treatment. To date, more than 10,000 patients with symptomatic uterine fibroids have been treated with the combination focused high intensity ultrasound waves (HIFU) and magnetic resonance (MR) imaging. Patients that undergo this out-patient procedure can typically return to normal activities in two days. At the same time, the procedure preserves the uterus and does not negatively impact a woman’s chances for pregnancy.
 
“Over the past three decades we have worked relentlessly to ensure innovative offerings in the field of healthcare,” said His Excellency Senator Dr. Zaid Kilani, Founder of Farah Hospital. “The journey of Farah Hospital will continue to create strong partnerships with reputable entities. We are honored to collaborate with Philips and we look forward to strengthening Jordan’s positioning as a regional hub for medical tourism.”
 
Kilani added: “ We are driven by the patient-focused care approach and we gear all our efforts towards ensuring a comfortable and trustworthy experience at our facility. Through the deployment of  state-of-the-art equipment we will challenge ourselves to introduce what best meets our patients’ needs benchmarked against the best possible medicine in Jordan and the world.”
 
“The introduction of the Sonalleve MR-HIFU system at Farah Hospital will raise the standards of care available to women in the entire region,” said Diederik Zeven, General Manager, Philips Healthcare Middle East and Turkey. “At Philips, we are committed to making a difference in improving the health and quality of women’s lives in the Middle East. Together with Farah Hospital, we are focused on providing women in the region with treatment options that result in better outcomes and improve their quality of life.”
 
Philips is dedicated to creating the future of healthcare and saving lives through meaningful innovation. A focus area of the company is the development of novel image-guided interventions and therapies such as MR-HIFU-based treatments. Philips’ Sonalleve MR-HIFU system uses high intensity focused ultrasound (HIFU) to direct sound energy into a tumor. This sound energy is then absorbed by the tumor tissue generating heat. The technique is capable of achieving tissue temperatures in excess of 65 degrees Celsius, high enough to kill tumor cells without damaging the surrounding tissue. Magnetic Resonance (MR) imaging provides real-time imaging of soft tissue structures so that the HIFU beam can be accurately focused onto the tumor. It also spatially maps local tissue temperatures in order to provide real-time feedback for controlling the applied temperature profiles.
 
Philips is committed to work with local stakeholders to develop solutions that deliver value throughout the continuum of care, from diagnosis to treatment and monitoring, and after care. To further demonstrate this commitment, Philips  participated in  the World Economic Forum on the Middle East and North Africa 2013 that was recently held in Jordan. The company was part of  discussions on how to improve access to healthcare through partnerships that support the needs of a rapidly growing population and facilitate a more sustainable future in healthcare.
 
Farah  Hospital is currently undergoing an expansion strategy and the construction of its new facility catered towards general medicine will be the first  LEED (Leadership in Energy Efficiency and Environmental Design) certified hospital in Jordan. LEED is a rating system created by the United States Green Building Council, and is widely accepted as the international standard for Green Building certification. Energy efficient lighting can play an important role in not only ensuring more sustainable healthcare facilities, but can also affect the health and well-being of patients and their caregivers.

Farah Medical Complex

MR-HIFU treatment

Philips MR-HIFU

Philips Sonalleve MR-HIFU

For further information, please contact:

Sarah Campbell
Philips Middle East
Tel: +971 55 100 3806
Email: sarah.campbell@philips.com 
 
Steve Klink
Philips Corporate Communications
Tel: +31 6 10888824
Email: steve.klink@philips.com

.

About Royal Philips:

Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 116,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter.

.